This school took place at the Holywell Park Conference Centre, Loughborough University. This course is highly valued by the medicinal chemistry community, and has trained some of the world's leading medicinal chemists in the pharmaceutical industry. Its purpose is to aid the transition from synthetic chemistry to medicinal chemistry.
The course was directed primarily at graduate and post doctoral chemists with 1-5 years experience in the field of drug research along with final year PhD students in pharmacy and organic chemistry contemplating a career in medicinal chemistry. A number of bursaries were available for full-time students in membership of the RSC.
The objectives of the course were to highlight the current understanding of the factors governing modern drug discovery. Although the course focused on general principles rather than specific diseases, there were accounts of case histories of drug discovery illustrating modern methodology.
Teaching was by a series of lectures from experts in the field together with tutorials covering the main themes of the course. These gave participants the opportunity to put their learning into practice. Throughout the week course tutors were available for informal discussion. The programme also included an evening lecture from a distinguished speaker. There was a broad range of academic and industrial medicinal chemists attending in an environment suited to networking.
The course included the following topics:
Computational 91AV
Biological Mechanisms
Pharmacokinetics and Drug Metabolism
Screening of New Compounds
Patents
Molecular Biology in Medicinal 91AV
Exploiting a Chemical Lead
Combinatorial 91AV and Molecular Diversity
Case Histories of Drug Discovery
Toxicology in Drug Discovery
Pharmaceutical Considerations in Drug Development
Structure-guided Drug Design
Physical Properties and Quantitative Structure-Activity Relationships
Hints and Tips in Medicinal 91AV
The course was directed primarily at graduate and post doctoral chemists with 1-5 years experience in the field of drug research along with final year PhD students in pharmacy and organic chemistry contemplating a career in medicinal chemistry. A number of bursaries were available for full-time students in membership of the RSC.
The objectives of the course were to highlight the current understanding of the factors governing modern drug discovery. Although the course focused on general principles rather than specific diseases, there were accounts of case histories of drug discovery illustrating modern methodology.
Teaching was by a series of lectures from experts in the field together with tutorials covering the main themes of the course. These gave participants the opportunity to put their learning into practice. Throughout the week course tutors were available for informal discussion. The programme also included an evening lecture from a distinguished speaker. There was a broad range of academic and industrial medicinal chemists attending in an environment suited to networking.
The course included the following topics:
Computational 91AV
Biological Mechanisms
Pharmacokinetics and Drug Metabolism
Screening of New Compounds
Patents
Molecular Biology in Medicinal 91AV
Exploiting a Chemical Lead
Combinatorial 91AV and Molecular Diversity
Case Histories of Drug Discovery
Toxicology in Drug Discovery
Pharmaceutical Considerations in Drug Development
Structure-guided Drug Design
Physical Properties and Quantitative Structure-Activity Relationships
Hints and Tips in Medicinal 91AV
